NURECA
₹423.55
44.85 (11.84%)
As on 03 June, 2023 | 23:25 BSE: 543264 NSE: NURECA

Nureca Performance

Day Range

  • Low
  • High
423.55

52 Week Range

  • Low
  • High
423.55
  • Open Price
  • Previous Close
  • Volume

Start SIP in Nureca

Start SIP

Nureca Share Price

  • Over 1 Month 27.38%
  • Over 3 Month 19.77%
  • Over 6 Month -18.52%
  • Over 1 Year -64.02%

Nureca Key Statistics

P/E Ratio -51.3
PEG Ratio 0.4
Market Cap Cr 424
Price to Book Ratio 2.2
EPS -8.4
Dividend 0
Relative Strength Index 83.87
Money Flow Index 97.46
MACD Signal -0.62
Average True Range 16.73

Nureca Investment Rating

  • Master Rating:
  • Nureca has an operating revenue of Rs. 111.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -55% needs improvement, Pre-tax margin of -10% needs improvement, ROE of -4% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 28% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 16 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 90 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Nureca Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 2128372641
Operating Expenses Qtr Cr 2529423244
Operating Profit Qtr Cr -4-1-5-5-3
Depreciation Qtr Cr 11111
Interest Qtr Cr 00000
Tax Qtr Cr 00-1-1-1
Net Profit Qtr Cr -20-3-4-1

Nureca Technicals

EMA & SMA

Current Price
₹423.55
44.85 (11.84%)
  • Bullish Moving Average
  • ___
  • 13
  • Bearish Moving Average
  • ___
  • 3
  • 20 Day
  • ₹338.54
  • 50 Day
  • ₹341.74
  • 100 Day
  • ₹394.48
  • 200 Day
  • ₹555.72
  • 20 Day
  • ₹333.68
  • 50 Day
  • ₹329.92
  • 100 Day
  • ₹354.79
  • 200 Day
  • ₹561.91

Nureca Resistance and Support

PIVOT
₹357.8
Resistance
First Resistance ₹399.6
Second Resistance ₹420.5
Third Resistance ₹462.3
RSI 83.87
MFI 97.46
MACD Single Line -0.62
MACD 7.54
Support
First Resistance ₹336.9
Second Resistance ₹295.11
Third Resistance ₹274.2

Nureca Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 5,903,203 38,547,916 6.53
Week 1,481,337 14,887,441 10.05
1 Month 368,873 4,791,664 12.99
6 Month 377,044 5,546,316 14.71

Nureca Result Highlights

Nureca Synopsis

NSE-Medical-Products

Nureca Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 111.90 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2023. Nureca Ltd. is a Public Limited Listed company incorporated on 02/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24304MH2016PLC320868 and registration number is 320868.
Market Cap 424
Sales 112
Shares in Float 0.37
No of funds 5
Yield 1
Book Value 2.17
U/D Vol ratio 7.9
LTDebt / Equity
Alpha -0.39
Beta 0.72

Nureca

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 62.98%62.98%70%70%
Mutual Funds 1.35%
Foreign Portfolio Investors 0.1%0.1%1.67%12.04%
Financial Institutions/ Banks 0.55%3.88%
Individual Investors 34.06%34.17%25.85%8.54%
Others 2.86%2.75%1.93%4.19%

Nureca Management

Name Designation
Mr. Saurabh Goyal Chairman & Managing Director
Mr. Aryan Goyal WholeTime Director & CEO
Mr. Rajinder Sharma Whole Time Director
Mrs. Charu Singh Independent Director
Mrs. Ruchita Agarwal Independent Director
Mr. Vijay Kumar Sharma Independent Director
Dr. Vikram Chaudhery Independent Director
Mr. Nitin Ravindra Bidikar Independent Director
Dr. Shrikant Uttam Tamhane Independent Director

Nureca Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nureca Corporate Action

Date Purpose Remarks
2023-05-23 Audited Results & A.G.M.
2023-02-03 Quarterly Results
2022-11-11 Quarterly Results
2022-08-12 Quarterly Results
2022-05-28 Audited Results & A.G.M.
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend

Nureca MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Nureca FAQs

What is Share Price of Nureca ?

Nureca share price is ₹423 As on 03 June, 2023 | 23:11

What is the Market Cap of Nureca ?

The Market Cap of Nureca is ₹423.6 Cr As on 03 June, 2023 | 23:11

What is the P/E ratio of Nureca ?

The P/E ratio of Nureca is -51.3 As on 03 June, 2023 | 23:11

What is the PB ratio of Nureca ?

The PB ratio of Nureca is 2.2 As on 03 June, 2023 | 23:11

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number